These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 18161156

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [New development in bisphosphonate treatment. Bisphosphonates for the treatment of glucocorticoid-induced osteoporosis].
    Soen S.
    Clin Calcium; 2009 Jan; 19(1):44-53. PubMed ID: 19122264
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Anabolic therapy in glucocorticoid-induced osteoporosis.
    Sambrook PN.
    N Engl J Med; 2007 Nov 15; 357(20):2084-6. PubMed ID: 18003966
    [No Abstract] [Full Text] [Related]

  • 5. Update on glucocorticoid-induced osteoporosis.
    Maricic M.
    Rheum Dis Clin North Am; 2011 Aug 15; 37(3):415-31, vi. PubMed ID: 22023900
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Efficacy of teriparatide in treatment of glucocorticoid-induced osteoporosis].
    Soen S.
    Clin Calcium; 2012 Mar 15; 22(3):315-20. PubMed ID: 22370297
    [Abstract] [Full Text] [Related]

  • 8. Teriparatide or alendronate in glucocorticoid-induced osteoporosis.
    Rossi CM, Di Comite G.
    N Engl J Med; 2008 Mar 20; 358(12):1302; author reply 1303-4. PubMed ID: 18354112
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Teriparatide or alendronate in glucocorticoid-induced osteoporosis.
    Babb RR.
    N Engl J Med; 2008 Mar 20; 358(12):1302-3; author reply 1303-4. PubMed ID: 18357641
    [No Abstract] [Full Text] [Related]

  • 11. Screening and treatment of glucocorticoid-induced osteoporosis in rheumatoid arthritis patients in an urban multispecialty practice.
    Ledwich LJ, Clarke K.
    J Clin Rheumatol; 2009 Mar 20; 15(2):61-4. PubMed ID: 19265346
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Introduction. D-hormones alfacalcidol and calcitriol for prevention and treatment of glucocorticoid/inflammation-induced osteoporosis.
    Sambrook PN, Schacht E.
    J Rheumatol Suppl; 2005 Sep 20; 76():1-3. PubMed ID: 16142844
    [No Abstract] [Full Text] [Related]

  • 15. [Rheumatoid arthritis and osteoporosis: trends in their treatments].
    Tanaka Y.
    Nihon Rinsho; 2006 Dec 20; 64(12):2359-66. PubMed ID: 17154104
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [New therapeutic approach in glucocorticoid-induce osteoporosis].
    Jakob F, Nitschmann S.
    Internist (Berl); 2008 Dec 20; 49(12):1524-5. PubMed ID: 19018505
    [No Abstract] [Full Text] [Related]

  • 18. Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis.
    Kishimoto M, Oishi A, Motojima S.
    N Engl J Med; 2006 Nov 16; 355(20):2156; author reply 2157. PubMed ID: 17108350
    [No Abstract] [Full Text] [Related]

  • 19. [Activate vitamin D3 or bisphosphonate in glucocorticoid-induced osteoporosis].
    Imanishi Y, Nishizawa Y.
    Clin Calcium; 2006 Nov 16; 16(11):1844-50. PubMed ID: 17079851
    [Abstract] [Full Text] [Related]

  • 20. [Secondary osteoporosis. A review of recent evidence focusing on glucocorticoid-induced osteoporosis and osteoporosis associated with rheumatoid arthritis].
    Suzuki Y.
    Clin Calcium; 2007 Jan 16; 17(1):104-7. PubMed ID: 17211102
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.